BRAINCOOL AB (5YL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BRAINCOOL AB (5YL) has a cash flow conversion efficiency ratio of -0.135x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-23.69 Million ≈ $-27.70 Million USD) by net assets (€175.80 Million ≈ $205.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BRAINCOOL AB (5YL) net asset quality to measure how much of total assets are equity-financed.
BRAINCOOL AB - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how BRAINCOOL AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore 5YL operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
BRAINCOOL AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BRAINCOOL AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Agat Ejendomme A/S
CO:AGAT
|
0.005x |
|
Zodiac Clothing Company Limited
NSE:ZODIACLOTH
|
-0.076x |
|
Caravelle International Group
NASDAQ:HTCO
|
-0.150x |
|
NanoViricides Inc
NYSE MKT:NNVC
|
-0.222x |
|
Ecocab Co. Ltd
KQ:128540
|
0.095x |
|
Allied Industrial Ltd
TWO:4702
|
-0.006x |
|
Z-Com Inc
TWO:8176
|
-0.001x |
|
Dorsavi Ltd
AU:DVL
|
-0.251x |
Annual Cash Flow Conversion Efficiency for BRAINCOOL AB (2021–2025)
The table below shows the annual cash flow conversion efficiency of BRAINCOOL AB from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see 5YL market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €175.80 Million ≈ $205.53 Million |
€-52.68 Million ≈ $-61.58 Million |
-0.300x | +30.19% |
| 2024-12-31 | €145.93 Million ≈ $170.61 Million |
€-62.64 Million ≈ $-73.23 Million |
-0.429x | +21.58% |
| 2023-12-31 | €111.74 Million ≈ $130.63 Million |
€-61.16 Million ≈ $-71.50 Million |
-0.547x | -37.50% |
| 2022-12-31 | €116.23 Million ≈ $135.89 Million |
€-46.27 Million ≈ $-54.09 Million |
-0.398x | +25.74% |
| 2021-12-31 | €45.23 Million ≈ $52.88 Million |
€-24.25 Million ≈ $-28.35 Million |
-0.536x | -- |
About BRAINCOOL AB
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powe… Read more